Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 11,050 CBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 11,050 | n/a |
| May 22, 2026 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 6,090 | n/a |
| Jan 23, 2026 | Astria Therapeutics, Inc. (ATXS) | Disposition to Issuer | 263,321 | n/a |
| Jun 23, 2025 | GLYCOMIMETICS INC (CBIO) | Grant/Award | 9,023 | n/a |
| Jun 12, 2025 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 26,550 | n/a |
| May 22, 2025 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 12,500 | n/a |
| Jun 6, 2024 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |
| May 29, 2024 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 11,000 | n/a |
| Sep 14, 2023 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/Award | 6,500 | n/a |
| Jun 6, 2023 | Astria Therapeutics, Inc. (ATXS) | Grant/Award | 14,100 | n/a |